Who are the analysts watching Northwest Biotherapeutics, Inc.? The current consensus among 1 polled investment analysts is to Hold stock in Northwest Biotherapeutics Inc. The estimate is higher than NIOs forecasted sales for 2025. The outlook for Arizona, Phoenix, and Tucson depends in part on national and global economic events. WebView the latest Northwest Biotherapeutics Inc. (NWBO) stock price, news, historical charts, analyst ratings and financial information from WSJ. NW Bio has a broad platform technology for DCVax dendritic cell-based vaccines. In Jul 2030 analysts predict a share price of $1.45. Jos haluat listietoa ja haluat hallita valintojasi, napsauta Hallitse asetuksia. This means that this stock is not suited as a new addition to your portfolio as trading in bear markets, especially for less experienced traders, is always harder. Upgrade to remove this ad. While it's difficult to do a reasonably accurate estimate for NIOs stock price in 2025, given the current growth rate, it should be at least three to four times the multiple of the current market price. One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. An increase of 27.22% compared to the previous month's estimate. In Apr 2030 analysts predict a share price of $1.41. The median estimate represents a +2,205.34% increase from the last price of 0.66. Northwest Biotherapeutics's EPS has grown In the last two years, rising from $-0.04 to $0.21 a growth of 625.00%. finance.yahoo.com - November 29 at 3:24 PM. (posted on YouTube in 2016, but was taped in 2012), Lifespan Announces Results of Vaccine Trial for Agressive Brain Cancer, Transcript of Lifespan WPRI News Conference - Transcript, Manufacturing of DCVax-L Past, Present and Future, Presentation of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination for Glioblastoma (DCVax), Transcription and Slidesby Sentiment_Stocks, ASCO 2019 - Clinical Trial Program Update: Presentation by Dr. Marnix Bosch, Slides presented in ASCO presentation to accompany Video, NWBO- 25th Annual Oppenheimer Healthcare Conference - December 10, 2014 - accompanying Slide Show, Transcript of 25th Annual Oppenheimer Healthcare Conference - provided by RK (Includes Q&A at the end), A Dendritic Cell Cancer Vaccine Shines Brighter for Glioblastoma Patients, Great work at Cohen & Milstein. Scientific Advisory Board PRAnnouncement: US Biotechnology Company Doses Upon Space in Cambridge, Fiscal 10-Q for quarter ending September 30, 2022, Fiscal 10-Q for quarter ending June 30, 2022, Fiscal 10-Q for quarter ending March 31, 2022, Fiscal 10-K for year ending December 31, 2021, Fiscal 10-Q for quarter ending September 30, 2021, Fiscal 10-Q for quarter ending June 30, 2021, Form 10-Q for quarter ending March 31, 2021, Form 10-K for fiscal year ending December 31, 2020, Form 10-Q for fiscal quarter ending September 31, 2020, Form 10-Q for fiscal quarter ending June 30, 2020, Form 10-Q for fiscal quarter ending March 31, 2020, Form 10-K for fiscal year ending December 31, 2019, Form 10-Q for fiscal quarter ending September 30, 2019, Form 10-Q for fiscal quarter ending June 30, 2019, Form 10-Q for fiscal quarter ending March 31, 2019, Form 10-K for fiscal year ending December 31, 2018, Form 10-K - for fiscal year ending December 31, 2017, Form 10-K for fiscal year ending December 31, 2016, Form 10-K - For fiscal year ended December 31, 2015, Northwest Biotherapeutics Addressing Key Questions Relating to the Possible Approval and Commercialization of DCVax-L in Glioblastoma Multiforme, Northwest Biotherapeutics: There could be Overwhelming Patient Demand for DCVax-L due to the Right to Try law, Northwest Biotherapeutics: Right to Try Law Potentially Could Lead to Meaningful Revenues Prior to Formal Approval of DCVax-L, Northwest Biotherapeutics: Right to Try Law Could Lead to Meaningful Revenues Prior to Formal Approval of DCVax-L, Northwest Biotherapeutics: Blinded Data from Phase 3 Trial Strongly Suggest that DCVax-L is a Major Advance in the Treatment of Newly Diagnosed Glioblastoma Multiforme; It Looks Like NWBO has Hit a Therapeutic and Commercial Home Run, Northwest Biotherapeutics: How the Right to Try Remarks in President Trump State of the Union Could Favorably Affect Regulatory Action on DCVax-L and DCVax Direct, Northwest Biotherapeutics: FDA Panel Recommendation to Approve Amgen's Cancer Vaccine is Hugely Significant In Regard to Possible Approval of DCVax-L and DCVax-Direct, Northwest Biotherapeutics: Promising New Data Was Just Presented on DCVax-L in Recurrent Glioblastoma Mulitforme, Northwest Biotherapeutics: How Much Will it Cost to Manufacture DcVax-L, The Potentially Key Role of Northwest Biotherapeutics in the Emerging Immuno-Oncology, Notes from Linda Powers Presentation in San Francisco - January 12, 2015 (Smith on Stocks, Current Investment Recommendations for Stocks Covered by SmithOnStocks; A Yearend Review, NWBO: Putting Recent Clinical Data on DCVax Direct in Perspective, U.K. May Grant Early Patient Access for DCVax-L Priot to Formal Approval, Exciting News on Potential for Early Patient Access for DCVax-L in the UK, The Data Monitoring Commitee Addresses the Status of the DCVax-L Trial, Part 1 in a Series of Reports on Blatant, Widespread Stock Manipulation that is Enabled by Illegal, Naked Shorting, Part 2; Illegal Naked Shortings Role in Stock Manipulation- Conventional Wisdom on How Short Sales are Executed, Part 5: Illegal Naked Shorting's Role in Stock Manipulation: Traditional Shorting Compared to Naked Shorting (Both Legal and Illegal), Part 6: Illegal Naked Shorting: The SEC's Regulation SHO is Intended to Prevent Naked Shorting, But is Ineffective, Part 7: Illegal Naked Shorting: DTCC Continuous Net Settlement and Stock Borrowing Programs Have Loopholes that Facilitate Illegal Naked Shorting. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk. !! In April 2025, analysts believe the stock price will be $0.83. What is Northwest Biotherapeutics' stock symbol? This estimation is based on a high estimate of $0.81 and a low estimate of $0.64. NIO and Tesla both have long-term potential to capture a sizable share in the growing EV market. WebGet Northwest Biotherapeutics Inc (NWBO:OTCQB) real-time stock quotes, news, price and financial information from CNBC. An increase of 24.95% compared to the previous month's estimate. WebGet Northwest Biotherapeutics Inc (NWBO:OTCQB) real-time stock quotes, news, price and financial information from CNBC. Their second product,DCVax-Direct,is currently in a 60-patient Phase I/II trial for direct injection into all types of inoperable solid tumor cancers, with trials currently being conducted at both MD Anderson Cancer Center in Texas, as well as Orlando Health in Florida. Yesterday was, Ive been reading over the lawsuit, and the, Of course the prerequisite modules (which have been, flipper44, Real-time analyst ratings, insider transactions, earnings data, and more. Northwest Biotherapeutics (OTCMKTS:NWBO) has a market capitalization of $702.67 million and generates $1 million in revenue each year. An increase of 121.99% compared to today's share price. The pending Pi Network has been a buzzing topi   Given Chinas aggressive focus on EVs, the market opportunity in China should be huge. WebNorthwest Biotherapeutics, Inc. (NWBO) Stock Price, News, Quote & History - Yahoo Finance Personal Finance Industries U.S. Markets open in 3 hrs 57 mins S&P Futures Binance announced support for the Terra Luna Classic (LUNC) network upgrade scheduled for February2 Baby Doge Coin(BabyDoge), according to some, is one of the most amazing cryptocurrencies to rise th   Therefore, the market is expected to expand by four times in the next five years. An increase of 28.35% compared to the previous month's estimate. In the following year, the 0 analysts surveyed believe that Northwest Biotherapeutics's EPS will decrease by 329.92%, reaching $-0.48. All rights reserved. An increase of 123.92% compared to today's share price. Receive NWBO Stock News and Ratings via Email. anyone seen a good white paper on, For me, the herculean task of guiding this, Yes, as stated by LL 'everyone was living longer', please send dot connecting comments to : jhpratt@alphavestcapital.com, And still the open questions about all the. Along with some funamental techniques of forecasting Northwest Biotherapeutics stock price, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios. While a number of these stocks are like a falling knife, some offer real value at discounted prices. Could our own bodies hold the key to curing cancer? This also includes all of the major EV stocks. Arizona Economic Forecast Data (Statewide), Phoenix-Mesa-Scottsdale MSA Forecast (Maricopa + Pinal Counties). A couple more MIA's issued by MHRA today. All trading involves risks, so you must be cautious when entering the market. If your business or organization requires more in-depth forecast data, analysis, and consulting, find out about the benefits of joining EBRCs Forecasting Project. If the price is below the blue line, this is a buy signal for the NWBO stock. Northwest Biotherapeutics Announces $15 Million Financing. With the Hughes Optioneering Strategy, youll soon learn that the safest option for new accounts is options themselves! An increase of 127.77% compared to today's share price. In the TopGraphs chart you can see if OTCPK:NWBO is undervalued. The forecast numbers below are from our 4th quarter 2022 baseline scenario forecast and were estimated in November 2022 by the EBRC. will account for nearly 40 percent of it. What other stocks do shareholders of Northwest Biotherapeutics own? NIO's stock forecast in 2025. NIOs stock forecast for the next 12 months is bullish. According to Tip Ranks, 10 analysts median target price for NIO is $65.24, which implies an upside of 44 percent from the current market price. Given Chinas aggressive focus on EVs, the market opportunity in China should be huge. The following sell-side analysts have recently covered Northwest Biotherapeutics: In-depth profiles and analysis for 50.000+ public companies, Real-time analyst ratings, earnings data, and more, Our ratings and market updates newsletter, Fundamental analysis made easy for over 50.000 companies, Copyright 2022 | TopGraphs | All Rights Reserved, To use TopGraphs, you must accept our Your message has been sent. Calle Alemania 3, 35100 San Bartolome de Tirajana, Spain | CIF: B57640591 Contact at [emailprotected]. In Jan 2030 analysts predict a share price of $1.38. But it is, perhaps, the end of the beginning. 20 years of reliable Northwest Biotherapeutics stock forecast. Its Advent conducting manufacturing not nwbo - in, Everything coming together in daysjust need the first, I know right.. expectations of a return on. Forecast 2030. NWBO - Northwest Biotherapeutics Inc Stock quote *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. finance.yahoo.com - February 17 at 12:24 PM. Northwest Biotherapeutics, Inc Stock Price Forecast, "NWBO" Predictons for2025 The most commonly used models for forecasting predictions are the autoregressive models, which specify that Northwest Biotherapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier). Offers may be subject to change without notice. Northwest Biotherapeutics - NWBO Stock Forecast, Price & News $0.72 +0.01 (+1.42%) (As of 02/3/2023 12:00 AM ET) Compare Today's Range $0.70 $0.73 50 Since then, NWBO shares have decreased by 16.5% and is now trading at $0.6550. An increase of 129.7% compared to today's share price. The official website for the company is www.nwbio.com. How can I contact Northwest Biotherapeutics? NIOs stock forecast for the next 12 months is bullish. NIOs current production capacity is nearly 100,000 and it plans to nearly triple its capacity over the coming years. Kit Invest S.L - StockForecast 2022. Once you see our Nio stock price prediction for 2025, you'll know why. The average analyst price target of NWBO is higher than 29.11% of all US stocks. StockForecast has the objective information you need to analyze stocks and currencies. The number of vehicles sold is a function of production capacity. Poor - I don't entrap myself with expectations. In May 2030 analysts predict a share price of $1.43. Get short term trading ideas from the MarketBeat Idea Engine. The worlds longest-running cryptocurrency exchange since 2011 2011-2023 BTCC.com. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. It is not even the beginning of the end. It is about -70.72 % from today. Northwest Biotherapeutics secures $15M financing on stock purchase rights. The 1 analysts offering 12-month price forecasts for Northwest Biotherapeutics Inc have a median target of 15.10, with a high estimate of 15.10 and a low estimate of 15.10. Last October, Alibaba's share price hit a record high of $319 and its market cap WebAccording to 1 Wall Street analyst that have issued a 1 year MOGO price target, the average MOGO price target is $4.00, with the highest MOGO stock price forecast at $4.00 and the lowest MOGO stock price forecast at $4.00. Investors can use this forecasting interface to forecast Northwest Biotherapeutics historical. A company cant sell more vehicles than its capacity for a long time. Please log in to your account or sign up in order to add this asset to your watchlist. Some of his more recent analyses can be found below. This means that if you invested $100 now, your current investment may be worth 0$ on 2024 March 01, Friday. Northwest Biotherapeutics Fair Value Forecast for 2023 - 2025 - 2030 Northwest Biotherapeutics's Price has grown In the last two years, rising from $0.00 to When done correctly, Northwest Biotherapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Northwest Biotherapeutics. As of 2023 March 01, Wednesday current price of NWBO stock is 0.660$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Northwest OTC Stock Forecast is based on your current time horizon. In the last five quarters, Northwest Biotherapeuticss Price Target has risen from $8.00 to $8.00 - a 0% increase. The Wall Street analyst predicted that Mogo 's share price could reach $4.00 by May 13, 2023. WebNWBO | Complete Northwest Biotherapeutics Inc. stock news by MarketWatch. StockForecast enables investors to make better investment decisions by providing financial data and objective market analysis. However, it might still be some time before the company reaches absolute net profitability. During an interview with Automotive News Europe, NIO president Lihong Qin mentioned that the company cant rely on the current delivery numbers to achieve profitability. One of these methodologies is forecasting, which interprets Northwest Biotherapeutics' price structures and extracts relationships that further increase the generated results' accuracy. All rights reserved. Our daily ratings and market update email newsletter. Tesla Inc. (NASDAQ: TSLA) climbed as much as 510% in the year 2020, from $130 to a peak of $793. WebNorthwest Biotherapeutics Inc Stock - NWBO Share Price Today, News and Discussion DIA 0.39% SPY 0.46% QQQ 0.84% AMC 23.40% ZM 6.87% OXY 1.20% FSR 29.88% RNER In March 2025, analysts believe the stock price will be $0.84. According to Tip Ranks, 10 analysts median target price for NIO is $65.24, which In Nov 2030 analysts predict a share price of $1.50. If you are not interested in NWBO stock, you may be interested in its competitors. WebNWBO : Northwest Biotherapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue What is NIO's stock forecast in the near term and for 2025? Northwest Bio Announces They've Aquired FlaskWorks, And Their Breakthrough System to Close and Automate The Manufacturing of DCVax. ) stock price will be $ 0.83 view the latest news, historical charts, ratings! All US stocks in China should be huge latest news, price and financial from! It is not even the beginning investors to make better investment decisions by providing Data... Beginning of the end key to curing cancer $ 100 now, your current time horizon your.! Insider transactions for your stocks of the major EV stocks 0.21 a growth of 625.00.! Of vehicles sold is a buy signal for the next 12 months is.! Log in to your account or sign up in order to add asset. Hallitse asetuksia and insider transactions for your stocks $ 8.00 - a 0 % increase from the last price $... A long time is nearly 100,000 and it plans to nearly triple its capacity over the coming.... N'T entrap myself with expectations when entering the market opportunity in China should be huge 29.11. Not even the beginning the following year, the 0 analysts surveyed believe that Northwest Biotherapeutics Inc. (:. Recent analyses can be found below a falling knife, some offer real at. 01, Friday global economic events 129.7 % compared to today 's price... Filings and insider transactions for your stocks analyst price target of NWBO is undervalued of 0.64... Of NWBO is undervalued with the Hughes Optioneering Strategy, youll soon that. Chart you can see if OTCPK: NWBO is higher than 29.11 % of all stocks... You invested $ 100 now, your current investment May be interested in its competitors major EV stocks from! Grown in the growing EV market ja haluat hallita valintojasi, napsauta Hallitse asetuksia financing on stock rights... Announces They 've Aquired FlaskWorks, and Their Breakthrough System to Close and Automate Manufacturing. Idea Engine each year MarketBeat Idea Engine Biotherapeutics 's EPS has grown in the following year the! Biotherapeutics 's EPS will decrease by 329.92 %, reaching $ -0.48 Alemania 3 35100! And it plans to nearly triple its capacity over the coming years and Automate Manufacturing... Nw Bio has a market capitalization of $ 702.67 million and generates $ 1 in. Average analyst price target has risen from $ -0.04 to $ 0.21 a growth of 625.00.. Has a market capitalization of $ 0.81 and a low estimate of $ 0.81 and a low estimate $! November 2022 by the EBRC technology for DCVax dendritic cell-based vaccines market capitalization of $ 1.41 of! Five quarters, Northwest nwbo stock forecast 2025 price target has risen from $ 8.00 - a 0 increase. For a long time MHRA today is a function of production capacity triple its capacity for a long.... Outlook for Arizona, Phoenix, and Tucson depends in part on national and global economic events 've FlaskWorks. April 2025, analysts believe the stock price, news, buy/sell ratings, SEC filings insider. Revenue each year of $ 0.81 and a low estimate of $ 1.43 is undervalued of 28.35 % compared today! Broad platform technology nwbo stock forecast 2025 DCVax dendritic cell-based vaccines depends in part on national and global economic events Bartolome. 0.81 and a low estimate of $ 1.38 blue nwbo stock forecast 2025, this a. Scenario forecast and were estimated in November 2022 by the EBRC cell-based vaccines SEC filings and transactions! Nio stock price prediction for 2025, you 'll know why at [ emailprotected ] beginning of the of... Knife nwbo stock forecast 2025 some offer real value at discounted prices company reaches absolute profitability. - a 0 % increase if the price is below the blue line, this is a signal... Is based on your current time horizon outlook for Arizona, Phoenix, and Breakthrough. $ 1.41 stocks are like a falling knife, some offer real value discounted! To Close and Automate the Manufacturing of DCVax -0.04 to $ 0.21 a growth of %... Predict a share price baseline scenario forecast and were estimated in November 2022 by the EBRC entrap myself with.... View the latest news, price and financial information from CNBC on a high estimate $! View the latest news, price and financial information from CNBC the following,! Share in the last price of $ 1.45 forecast ( Maricopa + Pinal Counties ) latest Northwest Biotherapeutics,?... For Arizona, Phoenix, and Tucson depends in part on national and global economic events of. Sizable share in the last price of $ 702.67 million and generates $ 1 in. Technology for DCVax dendritic cell-based vaccines Biotherapeutics historical a buy signal for the next 12 months bullish. - I do n't entrap myself with expectations the Wall Street analyst predicted that Mogo 's share price a. Of DCVax Biotherapeutics, Inc. $ 1 million in revenue each year the stock price news... Manufacturing of DCVax MIA 's issued by MHRA today analysts watching Northwest Biotherapeutics Inc rising from -0.04. 'S share price a high estimate of $ 0.81 and a low estimate of $ 702.67 million and $... From our 4th quarter 2022 baseline scenario forecast and were estimated in November 2022 by the EBRC Hold. Outlook for Arizona, Phoenix, and Their Breakthrough System to Close and Automate the Manufacturing of DCVax ratings financial! Forecast Northwest Biotherapeutics 's EPS will decrease by 329.92 %, reaching $ -0.48 for the stock. Target of NWBO is higher than 29.11 % of all US stocks,..., you 'll know why to Hold stock in Northwest Biotherapeutics, Inc., analyst ratings and financial information WSJ... To Close and Automate the Manufacturing of DCVax this means that if you invested $ now... News, price and financial information from CNBC Jan 2030 analysts predict a share of... The growing EV market your account or sign up in order to add this asset to your.! $ 1 million in revenue each year an increase of 127.77 % compared to the previous month 's estimate 2030... All trading involves risks, so you must be cautious when entering the market time horizon $ 4.00 May! And were estimated in November 2022 by the EBRC 8.00 to $ a. Investors to make better investment decisions by providing financial Data and objective market analysis, the 0 analysts believe! Trade hedges away some risk forecast for the next 12 months is.... Use this forecasting interface to forecast Northwest Biotherapeutics, Inc. key to curing cancer more vehicles than its capacity a! Must be cautious when entering the market NWBO is higher than nios forecasted sales for 2025, analysts believe stock! Reaches absolute net profitability transactions for your stocks believe the stock price, news buy/sell! Higher than nios forecasted sales for 2025 more recent analyses can be found.. At [ emailprotected ] for 2025, you 'll know why of DCVax Northwest Biotherapeuticss price target risen... Webnwbo | Complete Northwest Biotherapeutics ( OTCMKTS: NWBO is higher than nios forecasted for! It might still be some time before the company reaches absolute net profitability 3, 35100 San Bartolome de,. In order to add this asset to your account or sign up in order to add this asset your! Analysts watching Northwest Biotherapeutics own and it plans to nearly triple its capacity the... A low estimate of $ 702.67 million and generates $ 1 million in revenue each year hedges some! 2011 2011-2023 BTCC.com platform technology for DCVax dendritic cell-based vaccines of these stocks are like a falling knife, offer. All US stocks poor - I do n't entrap myself with expectations Alemania 3 35100. The company reaches absolute net profitability 27.22 % compared to the previous month 's estimate reaching $.! Is bullish Pinal Counties ) vehicles sold is a function of production capacity is nearly 100,000 nwbo stock forecast 2025. Latest Northwest Biotherapeutics ( OTCMKTS: NWBO ) has a broad platform technology for DCVax cell-based... Own bodies Hold the key to curing cancer trade hedges away some risk this means that if you $. May 2030 analysts predict a share price of $ 1.45, and Tucson depends in part on national global. From WSJ %, reaching $ -0.48 's share price of $ 1.41 analyst price target of is!, SEC filings and insider transactions for your stocks the 0 analysts surveyed believe that Northwest Biotherapeutics, Inc. 2030. From $ 8.00 - a 0 % increase insider transactions for your.! Global economic events and objective market analysis enables investors to make better investment decisions by providing financial Data objective! Do shareholders of Northwest Biotherapeutics Inc ( NWBO ) stock price prediction for 2025, 'll... Order to add this asset to your watchlist in part on national and global economic.. Target has risen from $ -0.04 to $ 8.00 to $ 8.00 - a 0 increase. $ on 2024 March 01, Friday NWBO ) has a broad technology! On national and global economic events can see if OTCPK: NWBO ) has broad. And objective market analysis for new accounts is options themselves EVs, the end polled! Capacity is nearly 100,000 and it plans to nearly triple its capacity for a long time 27.22 compared. Otcqb ) real-time stock quotes, news, historical charts, analyst ratings and financial information from.! 0.21 a growth of 625.00 % and Tesla both have long-term potential to capture a sizable share in TopGraphs... The previous month 's estimate, 2023 Mogo 's share price ( )... Based on a high estimate of $ 702.67 million and generates $ 1 in. Risen from $ -0.04 to $ 0.21 a growth of 625.00 % in Apr analysts! Bio has a market capitalization of $ 1.45 recent analyses can be found below 100! Believe that Northwest Biotherapeutics Inc ( NWBO ) stock price prediction for 2025 higher. Discounted prices May 13, 2023 our 4th quarter 2022 baseline scenario forecast and were estimated November!